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ABSTRACT
Recent deep-sequencing efforts have identified
many novel non-conserved small RNAs that are ex-
pressed at low levels in certain mammalian cells.
Whether these small RNAs are important for mam-
malian physiology is debatable, therefore we
explored the function of one such RNA, human
miR-1271. This small RNA is similar in sequence to
miR-96, a highly conserved microRNA that when
mutated causes hearing loss in humans and mice.
Although the miR-1271 and miR-96 sequences differ
slightly, our in vitro assays indicate that they have
an identical regulatory activity. We have identified
brain-expressed mRNAs from genes including,
GPHN, RGS2, HOMER1 and KCC2, which share the
same miR-96 and miR-1271 regulatory elements.
Interestingly, human miR-1271 is expressed abun-
dantly in brain tissue, where miR-96 is not highly
expressed. The rodent miR-1271 precursor
contains several sequence differences in the pre-
cursor stem, which appear to reduce the efficiency
of microRNA processing. Our data indicate that
although miR-1271 and miR-96 function identically
in vitro, they function to some extent uniquely
in vivo. Given the expression patterns and nature
of the target genes, miR-1271 may have a signifi-
cant, although non-conserved, role in regulating
aspects of neural development or function in
humans.
INTRODUCTION
The majority of mammalian protein-coding genes contain
microRNA-target motifs in their mature mRNA, which
function to regulate gene expression post-transcriptionally
(1). There is emerging evidence that speciﬁc microRNAs
control functionally integrated cellular pathways (1–3).
Given their potentially broad regulatory roles, it is not
surprising that individual microRNA genes have
emerged as important factors in the development of
several diseases, including psychiatric and neurological
disorders, as well as contributing to the molecular basis
of pharmacologic treatments (4–7). Dissecting the gene
networks impacted by these small regulators remains dif-
ﬁcult, especially in the central nervous system where there
is a complex cellular and structural environment and
where estimates suggest that 80% of all mRNAs
encoded by the mammalian genome are expressed (8). A
potential way to gain insight into the role of microRNA
regulation in human neurobiology is by characterizing
functional variants in microRNA genes or binding sites
and the factors that regulate their impact on associated
human behavioral phenotypes. This characterization
might provide insight into the epistasis of genes involved
in neural function and potentially elucidate novel neural
regulatory pathways in humans.
We recently described a common human polymorphism
in a microRNA target motif in the serotonin receptor 1B
(HTR1B) mRNA that attenuated miR-96
microRNA-directed regulation of gene expression in la-
boratory constructs (9). The microRNA-repressed form
of the variant was associated with an increased history
of self-reported externalized aggressive behaviors by
college-aged students (9) and higher average self
reported measures of hostile emotional states in the male
portion of the sample (10). These ﬁndings suggest that
regulation of gene expression by this miR-96 target
motif may have potential clinical relevance; therefore it
is important to better understand the factors that may
regulate gene expression via the HTR1B microRNA-
binding element as these may be involved in regulating
aspects of neural function relevant to human behavior.
Given that a functional mutation in the miR-96 gene
causes progressive hearing loss in adults without other
reported behavioral changes (11,12), and that miR-96
neural expression is prominent only in mammalian
sensory structures, we used in silico databases to identify
a second-potential microRNA, miR-1271, a non-
conserved small RNA identiﬁed by deep sequencing tech-
niques, that might regulate gene expression via the
HTR1B miR-96 motif as it shares a common ‘seed’
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identiﬁed by deep sequencing, the expression of miR-1271
in the tested tissues was extremely low, and whether it had
a signiﬁcant function in humans was in question.
Therefore in this study we compare and contrast the regu-
latory activities and expression patterns of miR-96 and
miR-1271. We have identiﬁed mRNAs targeted by the
common seed and note that they are enriched in genes
involved in neural signaling including, gephyrin
(GPHN), regulator of G protein signaling 2 (RGS2),
homer protein homolog 1 (HOMER1) and solute carrier
family 1 member 1 (SLC1A1). To test for potential in vivo
regulatory differences between these apparent homologs,
we examine the previously uncharacterized expression of
miR-1271 in neuronal and non-neuronal human and
rodent tissues.
MATERIALS AND METHODS
Plasmid constructs and RNA reagents
The luciferase test plasmids are a modiﬁed version of the
psiCHECK-2 (Promega, Madison, WI, USA) plasmid
described by Felice et al. (13). Synthetic sense and
anti-sense oligonucleotides representing the test element
(shown in Supplementary File 1 without restriction sites)
were designed to contain SacI and BstEII restriction sites
and were ligated into the renilla luciferase gene 30UTR
SacI and BsteII restriction sites. To ectopically express
miR-1271, a  250-nt portion of human or rat genome
containing the miR-1271 sequence was PCR ampliﬁed
with primers described in Supplementary File 1. The
ampliﬁed product was digested with BstEII and ClaI
restriction enzyme and sub-cloned down-stream of the
pSUPER H1 promoter cassette modiﬁed to contain the
BstEII and ClaI sites. The ‘HuRat’ miR-1271 precursor
insert was generated using a synthetic oligonucleotide
to introduce four single base changes in the rat gene
sequence. The 90-nt sense sequence is shown in
Supplementary File 1. The pSUPER H1 expression
cassette was sub-cloned into a pENTR11 (Invitrogen,
Carlsbad, CA, USA) shuttle vector containing a
membrane bound green ﬂuorescent protein (mGFP)
reporter gene expressed by a chicken b-actin promoter.
Human miR-1271 precursor RNA was purchased from
Ambion (Austin, TX, USA). UCDNA Services, Faculty
of Medicine, at the University of Calgary, Alberta,
Canada synthesized the precursor RNA for miR-96
[see ref (9)] and miR-600[G] RNA. The sequence of
miR-600[G], ACUUACGGACAAGAGCCUUGCUC,
was annealed to the passenger strand, miR-600[G]* GG
AAGGCUCUUGUCUGUCAGGCA. Argonaute 2
siRNA was from Dharmacon (Lafayette, CO, USA) and
Glyceraldehyde 3-phosphate siRNA was from Ambion
(Austin, TX, USA).
Cell culture and transfection experiments
HEK293 (ATCC CRL-1573) cells were cultured according
to ATCC speciﬁcations. For luciferase assay experiments,
2 10
5 or 1 10
5 HEK293 cells were seeded into either
12- or 24-well cell culture plates 24 h prior to transfection.
Cells were transfected with 50ng of luciferase plasmid
together with 0–2nM microRNA precursor using
Optimem I media and Lipofectamine 2000 according to
manufacture’s instructions (Invitrogen, Carlsbad, CA,
USA). Cells were incubated for 24 h then assayed for
ﬁreﬂy and renilla luciferase activity using the Dual
Luciferase Reporter Assay System (Promega, Madison,
WI, USA). Luminescence was measured with a 20/20
n
Luminometer (Turner Biosystems, Sunnyvale, CA, USA).
For gene knockdown experiments, HEK293 cells were
transfected with AGO2 or GAPDH siRNA at the time of
plating at a density of 1 10
5 cells per well (24-well
plates). Cells were grown for 12h then transfected with
50ng of luciferase plasmid and microRNA. Luciferase
activity and mRNA levels were measured after an add-
itional 18h of incubation.
Western blot analysis of gephyrin
For protein analysis, 48h after HEK293 cells were trans-
fected with microRNA, cells were washed once with phos-
phate buffered saline, removed from the plate with SDS
loading buffer, and heat denatured for 10min at 70 Ci n
the presence of 100mM dithiothreitol. 10mg of protein
was resolved on 10% SDS–PAGE, and transferred to
PVDF membrane. The membrane was blocked for 1h
with 3% bovine serum albumin diluted in TBS-T
(25mM Tris, 150mM NaCl, 1% Tween-20). The
membrane was incubated at 4 C overnight or at room
temperature for 1 h with goat anti-gephyrin polyclonal
antibody (sc-6411; Santa Cruz Biotechnology, Inc. Santa
Cruz, CA, USA) diluted 1:1000 or a-tubulin mouse mono-
clonal antibody from Abcam (ab7291; Abcam,
Cambridge, MA) at a 1:10000 dilution. Membranes
were washed three times for 5min with TBS (25mM
Tris, 150mM NaCl) and then incubated at room tempera-
ture for 1h with HRP conjugated secondary antibody
(Santa Cruz Biotechnology, Inc) diluted 1:12000.
Membranes were washed repeatedly with TBS (3 ) and
TBS-T (3 ), then incubated with Amersham ECL reagent
(GE Health Care, Piscataway, NJ, USA) and exposed to
ﬁlm.
RT–PCR analysis of gene expression
Forty-eight hours after HEK293 cells were transfected
with microRNA, total RNA was extracted with Trizol
(Invitrogen) for RT–PCR. Other sources of RNA for
RT–PCR included human forebrain cortex (Figure 4A;
Advanced Tissue Resource Center, Charlestown, MA,
USA), rat forebrain cortex (Figures 4A and 5C; adult
Brown Norway) or FirstChoice Human Total RNA
Survey Panel (Figures 4B and 5C; Ambion, Austin, TX).
Total RNA was reverse transcribed into cDNA using
random hexamers and the High Capacity cDNA Archive
Kit (Applied Biosystems) in a 20-ml reaction. RNA levels
for miR-96/1271 target genes and a normalizing gene,
b-glucuronidase, were measured using SYBR Green
qPCR and primers designed using Primer3 (14). Primer
sequences are listed in Supplemental File 1. One microlitre
of each cDNA reaction was used as template in a 10-ml
PCR reaction containing 250nM forward and 250nM
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Eugene, OR, USA), 1mg/ml Bovine serum albumin (New
England Bio Labs, Ipswich, MA) and 1 Gene
Expression Master Mix [Applied Biosystems (ABI),
Foster City, CA] using a ABI 7500 Real Time PCR
system. PCR cycles were; 95 C for 10min followed by
40 cycles of 95 C for 15 s and 60 C for 60 s. Levels of
b-glucuronidase mRNA were used for normalizing
microRNA expression levels between tissues in the
FirstChoice Human Total RNA Survey Panel. The
average Ct for brain RNA was used as a reference
point (i.e. 100%) for normalizing the expression values
from the different tissues in the Human Total RNA
Survey Panel.
MicroRNA gene expression assays were based on the
method described by Varkonyi-Gasic et al. (15). Of the
total RNA, 100ng was reverse transcribed in an 8-ml
reaction containing 1 pmole of microRNA gene speciﬁc
reverse transcription primer (described in Supplementary
File 1) and 20U of Superscript 3 enzyme (Invitrogen
Carlsbad, CA, USA). To measure the level of ectopically
expressed human or rat miR-1271, the reverse transcrip-
tion reaction was multiplexed to contain human or rat
speciﬁc miR-1271 and miR-16 gene speciﬁc reverse tran-
scription primers. miR-1271 and miR-16 were then PCR
ampliﬁed in separate reactions using 1ml of this common
reverse transcription reaction. The average miR-1271/
miR-16 Ct for the pSUP-HSA-1271 transfected cell
RNA was used as a reference (i.e. 100%) for the
microRNA induction experiment.
Statistics
Signiﬁcance (P<0.05) was determined with a one-sided
Student’s t-test unless noted otherwise.
RESULTS
miR-96 and miR-1271 regulate mRNA with similar
speciﬁcity
The miRBase (16) and TargetScan (1) microRNA data-
bases annotate two human microRNAs, miR-96 and
miR-1271, that have considerable sequence homology
(Figure 1A). The shared ‘seed’ sequence and the potential
interaction of miR-1271 with a previously studied poly-
morphic element in the human serotonin receptor 1B
mRNA suggested that these microRNAs might have
similar biological activities. Recent studies indicate that
nucleotides outside the seed may exert important control
over human microRNA function. For example, the
50-terminal nucleotide may control microRNA recruit-
ment into an effector protein complex and therefore
control microRNA activity (13,17). Also interactions
between nucleotides outside the ‘seed’ sequence of the
microRNA may provide an additional layer of mRNA
target speciﬁcation (18–20). Given that miR-96 and
miR-1271 differ in these sequences, we used a luciferase
reporter assay to test for potential similarities and differ-
ences in miR-96 and miR-1271 regulatory activity. In this
assay, a test element is inserted into the renilla luciferase
gene 30 untranslated region (UTR) and the regulatory
activity of that element is measured by normalizing
renilla luciferase enzyme activity to that of the ﬁreﬂy
luciferase enzyme expressed constitutively from the same
plasmid (Figure 1B). A microRNA response is evident
from a decrease in the ratio of renilla to ﬁreﬂy activity.
As shown in Figure 1B, insertion of the HTR1B
microRNA target A-element into the renilla 30UTR
confers a robust repressive effect by both miR-96 and
miR-1271. The A>G change associated with the human
single nucleotide polymorphism, rs13212041, results in an
attenuated response to both miR-96 and miR-1271. A
control RNA, miR-600[G] does not regulate either
element. Thus, we provide the ﬁrst evidence that
miR-1271 is indeed a functional microRNA and that it
regulates the naturally occurring polymorphic HTR1B
microRNA-binding element with the same speciﬁcity as
miR-96.
The sequence differences between miR-96 and
miR-1271 might allow each microRNA to interact with
target mRNA differently and thereby each may differen-
tially regulate a given mRNA. To more ﬁnely probe for
potential regulatory differences, we interrogated the
HTR1B A-element mRNA to identify the nucleotides
required for the miR-96 versus miR-1271 microRNAs to
regulate gene expression. We used this naturally occurring
element as a model test substrate because it responds
robustly to microRNA and it has extensive but distinct
complementarity to both miR-96 and miR-1271. This
allowed us to thoroughly test for potential nucleotide re-
quirements by mapping the element with point mutations.
At each position in a 22-nt element, single bases were se-
quentially changed such that potential Watson–Crick an-
nealing between the response element mRNA and
microRNA was disrupted. The regulatory response of
each targeted mutant element to miR-96 or miR-1271
was then tested. We observed that miR-96 and
miR-1271 regulate the mutated mRNA elements in a strik-
ingly similar fashion (Figure 1C). Each microRNA exerts
a repressive effect with all of the test elements that have
complete Watson–Crick complementarity between
microRNA nucleotides 2–8 and the HTR1B target
mRNA sequence. At each mutated position outside nu-
cleotides 2–8 in the 50 or 30 direction the response to either
microRNA is near wild-type levels. This is interesting,
given that the mRNA element has nucleotides at the
50 end that could potentially anneal to the more variable
30 regions of both microRNAs in Watson–Crick fashion.
Those potential interactions do not appear to be critical
for the repressive functions of either microRNA when
they act upon the HTR1B model test elements. It is also
worth noting that, although there is potential for strong
annealing elsewhere in the response element, these regions
cannot fully compensate for single changes to nucleotides
2–8. These observations reinforce the functional signiﬁ-
cance of the human single nucleotide polymorphism,
rs13212041, which is opposite the third nucleotide of
each microRNA. These ﬁndings also highlight the require-
ment for pairing between the microRNA ‘seed’ and the
target mRNA in order for gene silencing to occur for this
motif.
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with conserved RNA-binding proteins called argonautes.
The microRNA-directed silencing effects in HEK293 cells
appear to rely primarily on the expression of argonaute 2
(AGO2) (21). To test whether the sequence speciﬁc regu-
latory effects we observed were mediated by AGO2,w e
used siRNA to reduce AGO2 expression, and then tested
the repressive effect directed by each microRNA in the
luciferase assay. As shown in Figure 1D, pre-treating
HEK293 cells with siRNA targeting AGO2 mRNA de-
creases the silencing effect of each microRNA compared
to cells pretreated with siRNA targeting glyceraldehyde-3-
phosphate (GAPDH) or no siRNA. The silencing effect of
each microRNA was reduced  40% relative to mock
transfected cells or cells transfected with GAPDH
siRNA. We validated gene knock down by using RT–
PCR to measure the mRNA of each target gene relative
to b-glucuronidase. The average mRNA knockdowns in
four experiments were 92%±3.5 (SEM) for GAPDH and
74%±7.3 (SEM) for AGO2. Our data suggest that the
sequence speciﬁc regulatory effects of miR-96 and
miR-1271 in HEK293 cells are mediated largely by
Figure 1. Gene regulation by miR-1271 is disrupted by the HTR1B A/G 30UTR polymorphism. (A) Nucleotides that are common to microRNAs,
miR-1271 and miR-96 are indicated by grey shading. A dashed line indicates the ‘seed’ sequence, nucleotides 2–8. Shown below is the potential
interaction of both microRNAs with an element from the serotonin receptor 1B mRNA 30UTR. The location of the functional A>G rs13212041
SNP in the 30UTR opposite nucleotide 3 of the microRNA is indicated by bold italic. (B) The dual luciferase reporter plasmid used to test
microRNA response. The expression values in panels (B)–(D) are normalized for each construct to the expression value in the absence of
co-transfected microRNA. Similar to miR-96, miR-1271 regulates the expression of the HTR1B rs13212041 A-element, but not the G-element. A
control microRNA, miR-600[G], does not regulate the element with the same speciﬁcity. **P<0.005 comparing A-element to G-element in the
indicated conditions, and error bars indicate±SEM for 4-7 experiments. (C) MiR-96 and miR-1271 target HTR1B mRNA with similar speciﬁcity.
The HTR1B 30UTR based sequences used to test the nucleotide speciﬁcity of miR-96 and miR-1271 are described in detail in Supplementary File 1.
The position of each nucleotide change is numbered relative to the microRNA 50 end, i.e. mutant 1 is opposite nucleotide 1 of each microRNA.+1
to+3 indicates HTR1B 30 UTR nucleotides downstream from potential microRNA annealing site. The responses of each point mutant element to
miR-96 and miR-1271 are signiﬁcantly correlated, r=0.94, P<0.0001 (Pearson’s correlation). Error bars indicate±SEM for two experiments.
(D) MiR-96 and miR-1271 gene repression is argonaute 2 dependent. Asterisk indicates P<0.05 and error bars indicate±SEM for six to eight
experiments.
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may be due to incomplete knockdown of AGO2 or
perhaps compensation by other argonaute isoforms. It is
possible that miR-96 and miR-1271 utilize other
argonautes such as AGO1, AGO3 and AGO4 with differ-
ent regulatory effects and target speciﬁcity.
MiR-96 and miR-1271 regulate human genes involved in
neural signaling
Given the similarities we observed in the regulation of the
model test elements, we hypothesized that miR-96 and
miR-1271 could potentially target the same repertoire of
genes. To test this hypothesis, we focused on a set of genes
that are involved in processes related to neuronal excita-
tion e.g. glutamate signaling, synapse structure and
membrane electrical potential. Indeed, we noted that
many of the potential miR-96 and miR-1271 targets
annotated by the TargetScan (1) and miRanda (22) algo-
rithms are related to neural signaling. Potential miR-96/
miR-1271 targets include; two glutamate transporters
(SLC1A1, SLC1A2), four glutamate receptors (GRIN2B,
GRID1, GRIA1 and GRM7), two proteins that regulate
the activity of glutamate receptors (RGS2 and
HOMER1) (23,24), two enzymes involved in glutamate
and g-amino butyric acid metabolism (ABAT and
GAD2), and proteins such as neuroligin 2 (NLGN2) and
gephyrin (GPHN) that are involved in the post-synaptic
structure of inhibitory synapses (25,26). We also observed
this motif in the mRNA of the tachykinin 1 gene (TAC1),
which encodes the neuropeptides substance K and sub-
stance P, and the mRNA of SLC12A5 (also known as
KCC2), the gene that encodes the potassium chloride
symporter 2. KCC2 is important in the development and
control of the chloride ion gradient and in the regulation
of interneuron migration (27,28). The motif is also present
in the mRNA for glycoprotein M6a (GPM6A), a
stress-regulated protein expressed on the glutamatergic
axons of neurons in adult rat forebrain (29). We
sub-cloned fragments of the 30UTR containing the
putative miR-96/miR-1271 target elements from each of
these genes into the luciferase reporter construct to screen
for potential miR-96 and miR-1271 regulatory effects.
Upon co-transfection with microRNA, the majority (14/
19) of test element plasmids had a reduced ratio of renilla
to ﬁreﬂy luciferase expression indicating potential regula-
tion by miR-96 and miR-1271 (Figure 2A). Three genes
had two potential target sites, so in sum we observed that
75% (12/16) of the tested genes had an mRNA element
that responded to co-transfected miR-96 and miR-1271.
The miR-96 and miR-1271 repressive effects on each test
element were strikingly similar and highly correlated. We
further validated that the repressive effects of miR-1271
and miR-96 required a seed sequence match in the mRNA
for the genes that showed a repressive response in the
initial screen by mutating the third nucleotide of the
target site. As shown in Figure 2B, the repressive effect
of each microRNA was attenuated with test elements that
had a single nucleotide mismatch to nucleotide three of the
microRNAs. The regulatory response was also speciﬁc to
miR-96 and miR-1271, a control microRNA miR-600[G]
does not regulate the test elements.
HEK293 cells express several of the genes examined in
Figure 2 whose elements were regulated in the luciferase
assay. Therefore, we examined whether the level of en-
dogenous mRNA for four of these genes were reduced
in HEK293 cells in the presence of exogenous miR-96 or
miR-1271. As shown in Figure 3A, the mRNA from
SLC1A1, GPHN, RGS2 and HOMER1 genes was signiﬁ-
cantly reduced in cells transfected with miR-96 or
miR-1271 compared to mock transfected cells or cells
transfected with a control microRNA. The level of
SLC1A1, GPHN, RGS2 and HOMER1 mRNA was
reduced  60, 50, 40 and 30%, respectively, in either
miR-96 or miR-1271 transfected cells. The miR-96 and
miR-1271 effects on levels for each of these mRNAs
were similar. We additionally tested whether the
similarities we observed for regulation of mRNA were
also manifested at the protein level by examining the
protein expression for gephyrin, one of the more abun-
dantly expressed mRNAs. After 48h, HEK293 cells trans-
fected with miR-96 or miR-1271 had signiﬁcantly less
gephyrin protein than mock transfected cells or cells trans-
fected with a control microRNA (Figure 3B). There was a
signiﬁcant 2-fold decrease in gephyrin protein level in cells
transfected with either miR-96 or miR-1271. There was no
signiﬁcant difference in the level of gephyrin protein in
cells transfected with a control microRNA. Therefore,
we conclude that miR-96 and miR-1271 potentially
regulate the same genes including many that are
involved in neuron function.
Human miR-1271 and miR-96 are expressed in different
human tissues
Although, miR-96 and miR-1271 can function similarly in
HEK293 cells, their potential regulatory activity in vivo is
dependent upon their own pattern of expression, which
may differ temporally and spatially. The expression of
miR-96 has been extensively characterized in vertebrates.
In mammals, although miR-96 is detectable in brain, it is
considerably more abundant in sensory organ components
of the central nervous system including the retina, olfac-
tory bulb and inner ear, and therefore miR-96 is con-
sidered a sensory organ speciﬁc microRNA (30–32). Less
is known about the expression of human miR-1271. The
online repository for microRNA sequence data, miRBase
(16), only notes that miR-1271 has been identiﬁed experi-
mentally at low copy number by deep sequencing of small
RNA from human embryonic stem cells (33) and human
teratoma cell lines (34). Given that many of the target
mRNAs we tested are widely expressed in subsets of
brain neurons we hypothesized that miR-1271 would be
brain expressed. Indeed, as shown in Figure 4A, we detect
robust expression of miR-1271 in two human frontal lobe
cortex samples compared to miR-96, which, as expected
based on prior reports, was very low to undetectable.
Because we did not have RNA from human sensory
organs (i.e. tissues that would be expected to contain
abundant levels of miR-96), synthetic miR-96 was spiked
into the human brain RNA template prior to RT–PCR at
Nucleic AcidsResearch, 2011, Vol.39,No. 2 705a concentration that would correspond to  6000 copies
per cell. When the synthetic RNA is spiked into template
RNA samples, miR-96 is readily detected. The synthetic
miR-96 RNA positive control supports our conclusion
that there is a striking difference in miR-1271 and
miR-96 expression in human brain tissue.
We next tested whether miR-1271 was as abundant in
other human tissues, including non-neuronal tissues. As
shown in Figure 4B, miR-1271 expression was highest in
brain and skeletal muscle, followed by heart and bladder.
In brain and skeletal tissues, the level of miR-1271 relative
to b-glucuronidase was equal, while the levels in heart and
bladder were 60% and 70% less, respectively. Among the
tissues we tested, the level of miR-1271 was lowest in liver
(<5% of brain). An interesting feature of this expression
pattern is that the highest ranked tissues, brain, skeletal
muscle, heart and bladder, all contain a high level of ex-
citable cells such as neurons and muscle (skeletal, cardiac
and smooth).
A second striking difference between miR-96 and
miR-1271 is the difference in degree of conservation
between vertebrates. As shown in Figure 5A, the potential
Figure 2. MiR-96 and miR-1271 show similar regulation of target elements from multiple human genes involved in neuron function. (A) The
response of each test gene element to the indicated co-transfected microRNA is normalized to the activity of the test construct in the absence of
added microRNA.
aP<0.05 for both miR-96 and miR-1271,
bfor miR-1271 only and
cfor miR-96 only. The effects of each microRNA are
signiﬁcantly correlated, r=0.92, P<0.00001 (Pearson’s correlation). Error bars indicate±SEM for two experiments. (B) The repressive effects
of miR-96 and miR-1271 require a seed sequence match. Results for 11 targets that showed repressive effects of miR-1271/96 are illustrated. The
repressive effect of both miR1271 and miR-96 microRNAs is attenuated by a single nucleotide mismatch in the target site aligned with nucleotide 3
of the microRNA (designated as xx mut). Error bars indicate±SEM for three to six experiments. *P<0.05 compared to minus microRNA
condition. Hash (#) indicates a repressive effect (P<0.05) for the mutant GPHN element that is signiﬁcantly different than the wild type.
The response of each test gene element to the indicated co-transfected microRNA is normalized to the activity of the test construct in the
absence of added microRNA.
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mammals. More distant species, in particular, have a
number of nucleotide substitutions (rat=9, mouse=10)
that occur throughout the potential gene. A similar length
sequence encompassing miR-96 is identical between
human and rats, while the mouse sequence varies by
only one nucleotide (this difference is not in the mature
miR-96 sequence). We viewed the between-species differ-
ences in the miR-1271 gene precursor sequence as poten-
tially signiﬁcant because the precursor sequence forms a
speciﬁc secondary structure essential for proper
microRNA processing and expression. Therefore, we
hypothesized that the changes in the human sequence
may stabilize microRNA precursor secondary structure
and subsequent processing events leading to enhanced
microRNA expression. To test this, we compared the
expression of microRNA from the human and rat
miR-1271 genetic locus. We sub-cloned a  250-nt
portion of the potential precursors into an H1 promoter
controlled expression vector. The expression vector also
contained a green ﬂuorescent protein (GFP) gene as part
of a different transcriptional unit, which enables cell
tracking and assessment of transfection efﬁciency
between plasmids. After 48 h, the level of human
miR-1271 was increased more than 50-fold in HEK293
cells transfected with pSUP-HSA-miR-1271 compared to
cells transfected with the parental vector, pSUP-0
(Figure 5B). Expression of miR-1271 by the rat locus
was signiﬁcantly less than the human locus. To test
whether this blunted expression from the rat precursor
sequence was potentially from a defect in the hairpin
structure, we created a precursor sequence (HuRat) that
Figure 3. miR-1271 and miR-96 regulate neural gene expression in HEK293 cells. (A) The level of target gene mRNA in HEK293 cells is reduced by
miR-1271 and miR-96 transfection. The normalized level of the indicated target mRNA relative to b-glucuronidase (GUSB) is signiﬁcantly less in
cells transfected with 7.5nM of either miR-1271 or miR-96 compared to mock transfected cells. The mRNA levels were unchanged when the cells
were transfected with a control microRNA (miR-600[G]). Asterisk indicates P<0.05 and error bars indicate±SEM for three to four experiments.
(B) Gephyrin protein is reduced  55% in cells transfected with either miR-96 or miR-1271. The right panel summarizes the immunoblot
densitometry±SEM for four experiments, where 100% is the level of gephyrin/alpha-tubulin in mock-transfected cells.
Nucleic AcidsResearch, 2011, Vol.39,No. 2 707Figure 5. The expression of miR-1271 is not conserved in mammals. (A) The mammalian miR-1271 precursor sequence is divergent. Nucleotides
with white background differ from the human sequence. (B) By ectopically expressing the human miR-1271 genetic locus, miR-1271 can be induced
greater than 50-fold in HEK293 cells. No induction is evident with the parental plasmid, pSUP-0. MiR-1271 induction by the rodent gene is
signiﬁcantly blunted compared to human. By making changes that humanize the precursor sequence (underlined nucleotides, shown below the graph)
but leave the mature microRNA sequence unchanged, rodent miR-1271 expression is induced to the level of the human gene. Error bars
indicate±SEM for three experiments. (C) Rodent miR-1271 is expressed at reduced levels in rat brain. A brain expressed microRNA, miR-124,
serves as a positive control for microRNA detection in rat brain. (D) Human and rat ARL10 mRNA are expressed with very similar tissue speciﬁcity.
The partial structure of human and rat ARL10 and miR-1271 gene is shown above the graph showing relative ARL10 expression normalized to
GUSB for ﬁve tissues. The solid arrows indicate the position of primers used for RT–PCR. The dashed arrow indicates the direction of miR-1271.
Error bars indicate±SEM for two experiments.
Figure 4. miR-1271 and miR-96 have unique expression pattern in human nervous system tissue. (A) MiR-1271 is expressed robustly in human
frontal cortex while miR-96 is undetectable. Synthetic miR-96 RNA was spiked into the forebrain sample to conﬁrm that miR-96 could be detected
with this assay. (B) The expression pattern of miR-1271 in human tissue relative to b-glucuronidase (GUSB). The error bars indicate±SEM for two
experiments with pooled (three individuals) total RNA samples from each tissue.
708 Nucleic Acids Research, 2011,Vol. 39,No. 2had 4nt changes that potentially humanize the hairpin
structure without changing the sequence of the mature
rat microRNA (Figure 5B). We observed that the
humanized version of the rat precursor produces
microRNA levels similar to that of the human gene. The
human cell line we were using, HEK293, may have lacked
factors necessary for expression of the rat gene; therefore
we also examined endogenous miR-1271 expression in rat
brain. As shown in Figure 5C, we detect considerably less
miR-1271 in rat brain compared to human. To verify our
ability to detect microRNA expression in this tissue we
ampliﬁed the brain speciﬁc microRNA, miR-124 (35) as
a positive control and observed robust miR-124 expres-
sion. An alternative basis for low-miR-1271 expression in
rat brain compared with human brain might be that the
rodent miR-1271 precursor is expressed in a different
tissue pattern in rat versus humans. Human miR-1271
and the potential rat miR-1271 are each encoded within
intron 2 of ADP-ribosylation factor-like 10 (ARL10).
Intronic microRNAs are expressed from their host gene
as a single transcriptional unit; therefore, we tested
whether the host gene in each species was expressed simi-
larly (36,37). As shown in Figure 5D, ARL10 mRNA is
expressed with the same speciﬁcity in human and rat
tissues. The expression of ARL10 is highest in brain for
each species and lowest in liver. It is possible that the
wild-type rodent precursor is processed to a biologically
active small RNA sequence that is not detected by our
assay. However, our data do indicate that the subtle dif-
ferences in the microRNA precursor sequence that occur
between mammalian species have signiﬁcant effects on
miR-1271 processing and expression. Therefore, the ex-
pression of the functional miR-1271 may vary between
mammals and confer unique regulatory effects in humans.
DISCUSSION
Our ﬁndings provide an intriguing example of two human
microRNAs, miR-96 and miR-1271 that have the poten-
tial to act redundantly yet are expressed and perhaps
function in different human tissues. The expression of
the highly conserved miR-96 gene has been extensively
characterized in mammals where it is expressed in
sensory organs (30–32), while miR-1271 is a small RNA
that was only recently identiﬁed at low copy number in
human non-neuronal tissue. It could be argued that this
low level of expression renders miR-1271 with limited bio-
logical activity, yet our studies on human miR-1271 ex-
pression and function indicate that it likely has signiﬁcant,
although non-conserved, biological importance.
We used in silico databases to determine that the
miR-96/miR-1271 target motif is present in the mRNA
from several genes that are involved in neural signaling
and cell excitation, suggesting that either of these
microRNAs might have a role in regulating aspects of
human neural development or function. One target
protein that we have studied, gephyrin, is an important
structural anchor for GABAA and glycine receptors.
Loss of gephyrin expression results in reduced
post-synaptic glycine receptor numbers and altered
GABAA receptor subunit localization (26,38). Other
genes such as SLC12A5, HTR1B and the glutamate recep-
tors described in this paper also have signiﬁcant functions
in regulating cell excitation. Although not tested in this
article, TargetScan (1) also predicts the miR-96/miR-1271
target motif in the mRNA of other genes important for
cell excitation, including four voltage-gated sodium
channel subunits (SCN1A, SCN2A, SCN3A and
SCN9A) and four voltage-gated calcium channel
subunits (CACNA1C, CACNA2D2, CACNB1 and
CACNB4). Given that miR-1271 is highly expressed in
tissues that contain excitatory cells such as brain and
muscle, one function of miR-1271 might be to regulate
the development or maintenance of these processes. An
in-depth analysis of all potential targets may reveal add-
itional potential pathways or process regulated by
miR-1271. Regulation of cell excitation and neural trans-
mission are interesting characteristics that unify many
genes in the miR-96/1271 target gene set. However, the
conclusions that can be drawn from this observation
may be limited by the nature of the microRNA prediction
algorithm and the mRNA transcript database used as a
source of potential targets. Perhaps in this dataset, these
genes are over-represented as potential microRNA targets
because their mRNA transcripts are more extensively
characterized and annotated. However, it would be inter-
esting to see whether human variation in the mRNA
target site of any of these genes, as we have identiﬁed in
HTR1B, inﬂuence behavioral phenotypes relevant to psy-
chiatric disorders. Such a ﬁnding may yield additional
clues to the function of human miR-1271 in vivo.
Contrary to many well-characterized human
microRNA genes such as miR-96, the nucleotides in the
miR-1271 gene precursor are not highly conserved in
mammals. We have shown that by substituting four nu-
cleotides in the rat gene to generate a potentially
‘humanized’ secondary structure, the expression of a
miR-1271 gene product is signiﬁcantly enhanced.
Therefore, the precursor sequence differences that occur
between mammals may cause the small RNAs generated
from this locus to be processed with different efﬁciencies
or into different biologically active forms that confer
unique species-speciﬁc regulatory effects. According to
miRBase, the only other experimentally identiﬁed mam-
malian miR-1271 has been from dog lymphocyte RNA
(39). This expressed small RNA sequence resembles
human miR-1271 (Figure 5), however it is truncated
by two nucleotides on the 30 end. We have observed that
this sequence maps with 100% identity to at least three
regions of the canine genome (Chr4:40143926-40143945,
Chr15:54162445-54162464 and Chr38:4899026-4899045).
It is unclear the frequency at which this RNA was
detected and whether it is a bona ﬁde product of the
locus that is homologous to the human miR-1271 gene
or perhaps other regions of the canine genome. A more
rigorous examination of this genomic locus in all mamma-
lian species may provide insight into the mechanisms
involved in the genesis of this microRNA. These differ-
ences between mammals suggest that it is possible for
closely related species and perhaps even individuals of
the same species to differ in the number and identity of
Nucleic AcidsResearch, 2011, Vol.39,No. 2 709microRNA genes. Yet, for such a microRNA gene to
become ﬁxed in one species genome, it must impart
some beneﬁt to ﬁtness through regulatory interactions
with functional target mRNA motifs. MiR-1271 expres-
sion in humans may have developed to some extent as a
consequence of regulating mRNAs from genes with
miR-96 targets that are conserved in vertebrates and
also coincidently expressed with miR-1271.
The degree that human miR-1271 functions in human
tissues that have high-miR-96 expression, such as eye, ol-
factory bulb or inner ear remains untested. A more
thorough analysis of these tissues is warranted given the
recent reports showing that heritable mutations in the
miR-96 gene seed sequence are responsible for two inde-
pendent cases of familial non-syndromic progressive
hearing loss (11). Individuals bearing a mutated miR-96
gene might have a less pronounced sensory deﬁcit pheno-
type due to the potential compensatory activity of
miR-1271. Another potential way to distinguish between
the activities of each microRNA is to identify the proteins
that interact with them. This may provide insight into any
distinct functional roles not revealed in our studies.
In sum, we believe that human miR-1271 has regulatory
functions that are relevant to the biology of neurologic or
psychiatric disorders. We hope that our ﬁndings promote
a more thorough analysis of the function of novel human
small RNA genes discovered by deep sequencing tech-
niques. Although often detected at low copy number,
these genes may have important functions that are re-
stricted to certain tissues or developmental time periods.
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